HPV qualification panel
A new HPV genotype qualification panel expands the Sera- Care Women’s Health portfolio in response to the rapidly rising demand for products designed to meet the requirements for HPV assay qualification. The panel is derived from cultured human cells containing fulllength HPV DNA and includes the HPV 16 and HPV 18 genomes, which together account for an estimated 70 percent of all cases of the virus. The panel is designed to support assay qualification and testing by challenging every step in the process, from extraction through detection. The panel is designed for use with HPV test kits from Roche Molecular Diagnostics, Qiagen/digene and Hologic. In addition to supporting the vital process of assay verification, the panel can also be used for method comparison, reproducibility and lot-to-lot variability studies.
Supplier: SeraCare Life Sciences
Website:
